Endo-HIFU-R1 is a Phase 2 study designed to evaluate the safety of HIFU treatment of rectal endometriosis with EDAP’s Focal One® Robotic HIFU device. The study enrolled 60 patients across four ...

The objective of the study was to compare the management of rectal endometriosis with HIFU and surgery in terms of treatment-related improvements in symptoms and morbidity. The trial was designed ...

EDAP TMS Says FDA Grants Breakthrough Designation To Focal One For Rectal Endometriosis March 04, 2024 — 07:46 am EST Written by RTTNews.com for RTTNews -> ...

The Company recently completed a Phase 2 study evaluating HIFU as a potential treatment for deep infiltrating endometriosis. The Phase 2 study enrolled 60 subjects across four centers in France.

EDAP TMS Says FDA Grants Breakthrough Designation To Focal One For Rectal Endometriosis RTTNews Mar. 4, 2024, 07:46 AM ...

Endo-HIFU-R1 is a Phase 2 study designed to evaluate the safety of HIFU treatment of rectal endometriosis with EDAP’s Focal One® Robotic HIFU device. The study enrolled 60 patients across four ...